Compare · BEAT vs MDLN
BEAT vs MDLN
Side-by-side comparison of Heartbeam Inc. (BEAT) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BEAT and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 1977.4x BEAT ($24.3M).
- BEAT has been more active in the news (9 items in the past 4 weeks vs 7 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 10 for BEAT).
- Company
- Heartbeam Inc.
- Medline Inc.
- Price
- -
- -
- Market cap
- $24.3M
- $48.08B
- 1M return
- -
- +11.97%
- 1Y return
- -
- -11.77%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2025
- News (4w)
- 9
- 7
- Recent ratings
- 10
- 25
Heartbeam Inc.
HeartBeam, Inc., a medical technology company, primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease. It focuses on providing diagnostic data to help physicians with care management of patients with cardiovascular disease. The company is developing its telehealth product that comprises a credit card sized electrocardiograms machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is based in Santa Clara, California.
Latest BEAT
- HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
- SEC Form 4 filed by Heartbeam Inc.
- SEC Form 4 filed by Heartbeam Inc.
- SEC Form 4 filed by Heartbeam Inc.
- SEC Form 4 filed by Heartbeam Inc.
- SEC Form 4 filed by Heartbeam Inc.
- SEC Form 4 filed by Heartbeam Inc.
- Commercial Orders, FDA Firepower and Crypto Momentum
- HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment
- HeartBeam downgraded by H.C. Wainwright
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M